EX
Extendicare Inc.
EXETF · OTC
$19.41 +0.16% (+$0.03)
1M -12.57%
Market Cap $2.62B
P/E Ratio 21.56x
Div. Yield 1.93%
ROE 36.34%
Bulios Fair Price
$14.29
26.4% downside
Current Price
$19.41
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EXETF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
45 /100
Fair P/E 21.56x
EV/EBITDA 14.39x
PEG 0.95x
Growth
77 /100
Growing Rev. growth 10.74%
Book val. growth 54.73%
EPS growth N/A
Profitability
39 /100
Moderate Gross margin 31.56%
Net margin 6.13%
FCF margin 2.73%
Quality
81 /100
Excellent ROIC 11.41%
ROE 36.34%
Asset turnover 1.27x
Debt
42 /100
Moderate Debt/Equity 1.60x
Current ratio 0.75x
Net debt/EBITDA 2.50x
Stability
62 /100
Moderate Beta 1.16x
Rev. volatility 3.45%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EXETF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Michael R. Guerriere
Employees
23,500
Headquarters
Markham
Upcoming events
05 NOV
Earnings
Upcoming earnings report